Clinical Trial Update: Safety/Efficacy Trial of Killed Leishmania Vaccine in Volunteers With Positive Response to Leishmanin (LST>0) [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial update of a killed Leishmania vaccine tested in healthy volunteers, reporting safety and efficacy assessments with the study status listed as co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leishmaniasis

Drugs mentioned

• Killed Leishmania vaccine

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Healthy | Phase 2, Phase 3 | Status: COMPLETED